Table 2.
Estimated ratios comparing odds of achieving the quality outcomes of timeliness, completeness, or validity using specifically CD4a testing data, each week to the counterfactual scenario where the clinical laboratories in Côte d’Ivoire had not adopted OpenELISb,c.
| Preadoption weekly change in the slope of the outcome | Immediate level change during first week of OpenELIS implementation | Postadoption weekly change in slope of the outcome | ||||
| ORd (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Data timeliness | 1.03 (0.99-1.07) | .12 | 5.267 (4.33-6.41) | <.001 | 1.005 (0.99-1.02) | .49 |
| Data completeness | 1.11 (0.93-1.32) | .24 | 3.594 (2.40-5.37) | <.001 | 1.034 (1.02-1.05) | <.001 |
| Data validity | 1.00 (0.99-1.02) | .76 | 1.341 (0.69-2.60) | .38 | 0.994 (0.97-1.01) | .55 |
aCD4: clusters of differentiation 4.
bThe time period for this evaluation was 2014-2020.
cOpenELIS: Open-Source Enterprise-Level Laboratory Information System.
dOR: odds ratio.